LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended ...

On Carilion Clinic announced the installation of Usability Works, a biotechnology engineering consultancy. As a part of ...

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript March 30, 2026 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.2.

For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques ...

Moby summary of PDS Biotechnology Corporation's Q4 2025 earnings call ...

LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech ...

Billionaire Stephen Ross’ company buys Broward office for $37 million Nonprofit to lay off 53, close facility after loss of ...

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

PDS Biotechnology Corporation (PDSB) on Monday reported a loss of $7.6 million in its fourth quarter. The East Princeton, New Jersey-based company said it had a loss of 14 cents per share. For the ...

MANHATTAN BEACH, CA, UNITED STATES, April 3, 2026 /EINPresswire.com/ -- Driving Innovation and Growth in Biotechnology ...

The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: ...

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...